Loading…

Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient

•Multiple sclerosis can present with tumefactive relapsing lesions.•Brain biopsy could help in differential diagnosis.•Alemtuzumab led to a sustained remission after 4 years of follow-up.

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis and related disorders 2020-06, Vol.41, p.102061, Article 102061
Main Authors:	Baroncini, Damiano, Annovazzi, P., Guaschino, C., Minonzio, G., Hametner, S., Stadelmann, C., Comi, G., Ghezzi, A., Zaffaroni, M.
Format:	Article
Language:	English
Subjects:	Adolescent Alemtuzumab - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Brain Neoplasms - complications Brain Neoplasms - diagnostic imaging Humans Male Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging Multiple Sclerosis, Relapsing-Remitting - drug therapy Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443
cites	cdi_FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443
container_end_page
container_issue
container_start_page	102061
container_title	Multiple sclerosis and related disorders
container_volume	41
creator	Baroncini, Damiano Annovazzi, P. Guaschino, C. Minonzio, G. Hametner, S. Stadelmann, C. Comi, G. Ghezzi, A. Zaffaroni, M.
description	•Multiple sclerosis can present with tumefactive relapsing lesions.•Brain biopsy could help in differential diagnosis.•Alemtuzumab led to a sustained remission after 4 years of follow-up.
doi_str_mv	10.1016/j.msard.2020.102061
format	article
fullrecord	<record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_msard_2020_102061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2211034820301371</els_id><sourcerecordid>32203930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443</originalsourceid><addsrcrecordid>eNp9kM9KxDAQxoMouqz7BILkBbpmkjZuDx5k8R8seNFzSJOpZGnakqSC-vJmXd2jYWDCzPdlJj9CLoAtgYG82i591MEuOeO7CmcSjsiMc4CCiUoeH-7l6owsYtyyfGQFpYRTciY4Z6IWbEa-NkP_ViQMngb0LkY39HRoaZo8ttok94650ekxuv6N-qlLbuyQRtNhGKKLVLfZTHWHPk2fk9dNlkczIU0BdfLYJ-p6qnPYocudXWHUyeV8Tk5a3UVc_OY5eb2_e1k_Fpvnh6f17aYwgstUcCFECeJ6JS0rjWBQm0bDqgRrNbNtU3Nrr1nFJbKm1FULUEFdowSZRaIsxZyI_bsmrxwDtmoMzuvwoYCpHU21VT801Y6m2tPMrsu9a5waj_bg-WOXBTd7Aebd3x0GFU3-lkHrApqk7OD-HfANibOIhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient</title><source>ScienceDirect Journals</source><creator>Baroncini, Damiano ; Annovazzi, P. ; Guaschino, C. ; Minonzio, G. ; Hametner, S. ; Stadelmann, C. ; Comi, G. ; Ghezzi, A. ; Zaffaroni, M.</creator><creatorcontrib>Baroncini, Damiano ; Annovazzi, P. ; Guaschino, C. ; Minonzio, G. ; Hametner, S. ; Stadelmann, C. ; Comi, G. ; Ghezzi, A. ; Zaffaroni, M.</creatorcontrib><description>•Multiple sclerosis can present with tumefactive relapsing lesions.•Brain biopsy could help in differential diagnosis.•Alemtuzumab led to a sustained remission after 4 years of follow-up.</description><identifier>ISSN: 2211-0348</identifier><identifier>EISSN: 2211-0356</identifier><identifier>DOI: 10.1016/j.msard.2020.102061</identifier><identifier>PMID: 32203930</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Alemtuzumab - therapeutic use ; Antineoplastic Agents, Immunological - therapeutic use ; Brain Neoplasms - complications ; Brain Neoplasms - diagnostic imaging ; Humans ; Male ; Multiple Sclerosis, Relapsing-Remitting - complications ; Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging ; Multiple Sclerosis, Relapsing-Remitting - drug therapy ; Treatment Outcome</subject><ispartof>Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102061, Article 102061</ispartof><rights>2020 Elsevier B.V.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443</citedby><cites>FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443</cites><orcidid>0000-0003-4234-8956</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32203930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baroncini, Damiano</creatorcontrib><creatorcontrib>Annovazzi, P.</creatorcontrib><creatorcontrib>Guaschino, C.</creatorcontrib><creatorcontrib>Minonzio, G.</creatorcontrib><creatorcontrib>Hametner, S.</creatorcontrib><creatorcontrib>Stadelmann, C.</creatorcontrib><creatorcontrib>Comi, G.</creatorcontrib><creatorcontrib>Ghezzi, A.</creatorcontrib><creatorcontrib>Zaffaroni, M.</creatorcontrib><title>Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient</title><title>Multiple sclerosis and related disorders</title><addtitle>Mult Scler Relat Disord</addtitle><description>•Multiple sclerosis can present with tumefactive relapsing lesions.•Brain biopsy could help in differential diagnosis.•Alemtuzumab led to a sustained remission after 4 years of follow-up.</description><subject>Adolescent</subject><subject>Alemtuzumab - therapeutic use</subject><subject>Antineoplastic Agents, Immunological - therapeutic use</subject><subject>Brain Neoplasms - complications</subject><subject>Brain Neoplasms - diagnostic imaging</subject><subject>Humans</subject><subject>Male</subject><subject>Multiple Sclerosis, Relapsing-Remitting - complications</subject><subject>Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging</subject><subject>Multiple Sclerosis, Relapsing-Remitting - drug therapy</subject><subject>Treatment Outcome</subject><issn>2211-0348</issn><issn>2211-0356</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kM9KxDAQxoMouqz7BILkBbpmkjZuDx5k8R8seNFzSJOpZGnakqSC-vJmXd2jYWDCzPdlJj9CLoAtgYG82i591MEuOeO7CmcSjsiMc4CCiUoeH-7l6owsYtyyfGQFpYRTciY4Z6IWbEa-NkP_ViQMngb0LkY39HRoaZo8ttok94650ekxuv6N-qlLbuyQRtNhGKKLVLfZTHWHPk2fk9dNlkczIU0BdfLYJ-p6qnPYocudXWHUyeV8Tk5a3UVc_OY5eb2_e1k_Fpvnh6f17aYwgstUcCFECeJ6JS0rjWBQm0bDqgRrNbNtU3Nrr1nFJbKm1FULUEFdowSZRaIsxZyI_bsmrxwDtmoMzuvwoYCpHU21VT801Y6m2tPMrsu9a5waj_bg-WOXBTd7Aebd3x0GFU3-lkHrApqk7OD-HfANibOIhw</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Baroncini, Damiano</creator><creator>Annovazzi, P.</creator><creator>Guaschino, C.</creator><creator>Minonzio, G.</creator><creator>Hametner, S.</creator><creator>Stadelmann, C.</creator><creator>Comi, G.</creator><creator>Ghezzi, A.</creator><creator>Zaffaroni, M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-4234-8956</orcidid></search><sort><creationdate>202006</creationdate><title>Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient</title><author>Baroncini, Damiano ; Annovazzi, P. ; Guaschino, C. ; Minonzio, G. ; Hametner, S. ; Stadelmann, C. ; Comi, G. ; Ghezzi, A. ; Zaffaroni, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Alemtuzumab - therapeutic use</topic><topic>Antineoplastic Agents, Immunological - therapeutic use</topic><topic>Brain Neoplasms - complications</topic><topic>Brain Neoplasms - diagnostic imaging</topic><topic>Humans</topic><topic>Male</topic><topic>Multiple Sclerosis, Relapsing-Remitting - complications</topic><topic>Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging</topic><topic>Multiple Sclerosis, Relapsing-Remitting - drug therapy</topic><topic>Treatment Outcome</topic><toplevel>online_resources</toplevel><creatorcontrib>Baroncini, Damiano</creatorcontrib><creatorcontrib>Annovazzi, P.</creatorcontrib><creatorcontrib>Guaschino, C.</creatorcontrib><creatorcontrib>Minonzio, G.</creatorcontrib><creatorcontrib>Hametner, S.</creatorcontrib><creatorcontrib>Stadelmann, C.</creatorcontrib><creatorcontrib>Comi, G.</creatorcontrib><creatorcontrib>Ghezzi, A.</creatorcontrib><creatorcontrib>Zaffaroni, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Multiple sclerosis and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baroncini, Damiano</au><au>Annovazzi, P.</au><au>Guaschino, C.</au><au>Minonzio, G.</au><au>Hametner, S.</au><au>Stadelmann, C.</au><au>Comi, G.</au><au>Ghezzi, A.</au><au>Zaffaroni, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient</atitle><jtitle>Multiple sclerosis and related disorders</jtitle><addtitle>Mult Scler Relat Disord</addtitle><date>2020-06</date><risdate>2020</risdate><volume>41</volume><spage>102061</spage><pages>102061-</pages><artnum>102061</artnum><issn>2211-0348</issn><eissn>2211-0356</eissn><abstract>•Multiple sclerosis can present with tumefactive relapsing lesions.•Brain biopsy could help in differential diagnosis.•Alemtuzumab led to a sustained remission after 4 years of follow-up.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32203930</pmid><doi>10.1016/j.msard.2020.102061</doi><orcidid>https://orcid.org/0000-0003-4234-8956</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 2211-0348
ispartof	Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102061, Article 102061
issn	2211-0348 2211-0356
language	eng
recordid	cdi_crossref_primary_10_1016_j_msard_2020_102061
source	ScienceDirect Journals
subjects	Adolescent Alemtuzumab - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Brain Neoplasms - complications Brain Neoplasms - diagnostic imaging Humans Male Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging Multiple Sclerosis, Relapsing-Remitting - drug therapy Treatment Outcome
title	Long-term remission of tumefactive relapsing multiple sclerosis after alemtuzumab rescue treatment in an adolescent patient
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A54%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20remission%20of%20tumefactive%20relapsing%20multiple%20sclerosis%20after%20alemtuzumab%20rescue%20treatment%20in%20an%20adolescent%20patient&rft.jtitle=Multiple%20sclerosis%20and%20related%20disorders&rft.au=Baroncini,%20Damiano&rft.date=2020-06&rft.volume=41&rft.spage=102061&rft.pages=102061-&rft.artnum=102061&rft.issn=2211-0348&rft.eissn=2211-0356&rft_id=info:doi/10.1016/j.msard.2020.102061&rft_dat=%3Cpubmed_cross%3E32203930%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-2333413786d04c3019cba1841dda0dfb92dd70526e0b4a5f115199e6161843443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/32203930&rfr_iscdi=true